Dr. Feigal is a Principal in NDA Partners LLC and Adjunct Faculty at the O'Connor School of Law, Arizona State University where he teaches Food and Drug Law and policy and at the Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco. He has previous served as Vice President for Global Regulatory Affairs at Amgen and Senior Vice President for Global Regulatory and Safety at Élan Pharmaceuticals. His career in the development of medical therapeutics began with training as a physician epidemiologist with an M.D. degree from Stanford University and an M.P.H. from the University of California Berkeley. After his training in Internal Medicine he was a member of the full time faculty in the Schools of Medicine at the University of California at San Francisco and San Diego. He later spent twelve years at the US FDA heading the Antiviral Drug Division, the Anti-Infective Drug Division and ODE IV in the Center for Drug Evaluation and Research, the Medical Deputy Director in the Center for Biologics Research and Evaluation and serving as the Director of the Center for Devices and Radiological Health from 1999 to 2004.